Molecular mechanisms of HBV-associated hepatocarcinogenesis.
about
Molecular mechanism of hepatitis B virus-induced hepatocarcinogenesisMultidisciplinary perspective of hepatocellular carcinoma: A Pacific Northwest experience.Human endogenous retrovirus K and cancer: Innocent bystander or tumorigenic accomplice?Role of the Microbiota in Colorectal Cancer: Updates on Microbial Associations and Therapeutic ImplicationsLiver-specific expressions of HBx and src in the p53 mutant trigger hepatocarcinogenesis in zebrafishGenome-wide identification of direct HBx genomic targetsVirus-induced hepatocellular carcinoma with special emphasis on HBV.Viruses and human cancers: a long road of discovery of molecular paradigms.Viral hepatitis and hepatocellular carcinoma: etiology and managementAssociation between two common polymorphisms and risk of hepatocellular carcinoma: evidence from an updated meta-analysis.Transcription of hepatitis B virus covalently closed circular DNA is regulated by CpG methylation during chronic infectionHepatitis B virus X protein disrupts the balance of the expression of circadian rhythm genes in hepatocellular carcinomaSoluble MICB protein levels and platelet counts during hepatitis B virus infection and response to hepatocellular carcinoma treatment.Noncoding RNA as therapeutic targets for hepatocellular carcinoma.Clinicopathologic characteristics of SALL4-immunopositive hepatocellular carcinoma.Risk for hepatocellular carcinoma in the course of chronic hepatitis B virus infection and the protective effect of therapy with nucleos(t)ide analoguesOncogenic Wnt3a expression as an estimable prognostic marker for hepatocellular carcinoma.Upregulation of PP2Ac predicts poor prognosis and contributes to aggressiveness in hepatocellular carcinomaA predictive model for carcinogenesis in patients with chronic hepatitis B undergoing entecavir therapy and its validation.Hepatitis B virus X protein is capable of down-regulating protein level of host antiviral protein APOBEC3G.Icaritin inhibits the expression of alpha-fetoprotein in hepatitis B virus-infected hepatoma cell lines through post-transcriptional regulation.Autophagy: A novel therapeutic target for hepatocarcinoma (Review).Hepatocellular carcinoma in chronic hepatitis B patients under antiviral therapy.Chronic hepatitis B: role of anti-platelet therapy in inflammation control.Mechanism of Hepatitis B Virus Persistence in Hepatocytes and Its Carcinogenic Potential.Hepatitis B virus pre-S2 mutant large surface protein inhibits DNA double-strand break repair and leads to genome instability in hepatocarcinogenesis.A broadly reactive monoclonal antibody detects multiple genotypes of hepatitis B virus X protein.Triple Staining Including FOXA2 Identifies Stem Cell Lineages Undergoing Hepatic and Biliary Differentiation in Cirrhotic Human Liver.Identification of the novel 3' UTR sequences of human IL-21 mRNA as potential targets of miRNAs.Inhibitory effects of resveratrol on hepatitis B virus X-protein (HBx)-induced hepatocellular carcinoma (HCC).Multiple Hepatitis B Virus (HBV) Quasispecies and Immune-Escape Mutations Are Present in HBV Surface Antigen and Reverse Transcriptase of Patients With Acute Hepatitis B.Down-regulation of NTCP expression by cyclin D1 in hepatitis B virus-related hepatocellular carcinoma has clinical significance.Extended survival of patients with persistently suppressed hepatitis B transplanted for hepatocellular carcinoma.Presence of viral DNA in whole-genome sequencing of brain tumor tissues from the cancer genome atlasIdentification of additional EHMT2 variant associated with the risk of chronic hepatitis B by GWAS follow-up study.Poor outcome of hepatocellular carcinoma with stemness marker under hypoxia: resistance to transarterial chemoembolization.The incidence of hepatocellular carcinoma is reduced in patients with chronic hepatitis B on long-term nucleos(t)ide analogue therapy.The Role of Promyelocytic Leukemia Protein in Steatosis-Associated Hepatic Tumors Related to Chronic Hepatitis B virus Infection.Capable Infection of Hepatitis B Virus in Diffuse Large B-cell Lymphoma.The association of adverse outcomes in the mother with disease progression in offspring in families with clusters of hepatitis B virus infection and unfavorable prognoses in Northwest China
P2860
Q26823512-70848186-DE25-47F5-B478-0920E6A1494BQ26998606-F05886E8-C8ED-456A-A297-3097501A4E5AQ27010373-B641BE49-E7F8-459B-8E80-29310B676B31Q28073131-D49195CF-4700-488E-B2D3-D1C197AD29B3Q28534280-6EAE2BD7-C9FD-444F-A661-4C32B8EA77F0Q29048191-A6B25F28-999A-4B8B-A1C6-C4540AD685A3Q30238961-D0C0D6C0-B57B-4955-B52A-A43E37E8A491Q30384388-001DD057-41AA-470F-9C24-14E450FA26C1Q33593219-03093FFD-5089-481A-9A8D-3A4771F0A3DDQ33594041-EB752771-BD04-446E-967A-F73DFDB4D200Q34388160-F078615F-B86C-4531-879C-04EBB8B7B3C9Q34427154-E33C1461-F4CF-4D63-8F7B-F6C98BAAA720Q35053561-79B8DB0E-1E6F-457C-9FB6-C73043D5CCB1Q35592207-B9E31006-F85C-4DD7-BEC0-ED07ABB2453EQ35661679-C8E46D82-9849-436C-9CCF-8D92B76C5291Q35668724-64B11B6B-12EF-492B-BEB0-A9DDCE460197Q36747844-1F875388-4E65-4714-BF1D-0B24533C45BFQ36844274-5FCBBE5A-13A2-46B2-A19B-4F1193739212Q37257069-349B24C1-3FF2-4648-B00D-AA598E45492DQ37591195-868FC934-900D-4426-A58F-576E64887016Q37696374-9BC4BAD8-8426-4D4A-B7E2-B266CDAF4855Q37720015-6302B53D-CEDC-42A4-A83E-6FBB7E9CF966Q38174862-AAA8AD15-49E6-402D-9DF9-A1F3ACD53EFAQ38314202-F93DBE8D-371E-4BD3-B52A-E08EEE7A034BQ38837061-076A9F82-74B8-4F84-A610-B231E9237150Q38899314-EB47DF1B-96CF-4A02-A4A9-8EA6C5D8C87CQ38993996-52D1972E-6F75-4104-85D8-163FACF827CDQ39159595-4EFAA434-325A-4228-8DE9-018BC5687EABQ40086494-933284AD-3DE5-4068-B9ED-9C781D2EFE81Q40254603-D4807956-A96B-4C36-84F4-27ED8E8BB1CFQ40779997-BED484AD-BE54-4E37-BE3F-E94C049E2C0DQ41348023-A8BDC16C-B568-4B96-A5D8-C0A3A4277C36Q41384111-461F68A3-3C5A-4153-9023-C5C11203926CQ42668955-896241A2-7047-4AFD-ACE1-D23E67DAF0CEQ47565943-50B3AE6A-E8A9-4ED0-9142-FD14D2BF6181Q48196778-9F3C44B6-5755-4FAA-9AEF-6B990B5BDF9DQ51261488-801B8ECD-32D3-4EEE-A8B8-0DF2CFD8B86DQ52717366-B8280E0F-9AC4-42CE-B303-1556594BCABDQ55044828-6C2D9632-D5DE-4060-8811-11B7ADE24E93Q58704686-77D65B60-3B99-40A0-9CD0-0C66EEF86C47
P2860
Molecular mechanisms of HBV-associated hepatocarcinogenesis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Molecular mechanisms of HBV-associated hepatocarcinogenesis.
@en
type
label
Molecular mechanisms of HBV-associated hepatocarcinogenesis.
@en
prefLabel
Molecular mechanisms of HBV-associated hepatocarcinogenesis.
@en
P356
P1476
Molecular mechanisms of HBV-associated hepatocarcinogenesis
@en
P2093
Laura Belloni
Natalia Pediconi
P304
P356
10.1055/S-0033-1345721
P577
2013-05-01T00:00:00Z